Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 6, 2013, Pages 1221-1227

  Özdemir, Ahmet ^a   Altintop, Mehlika Dilek ^a   Kaplancikli, Zafer Asim ^a   Turan Zitouni, Gülhan ^a   Çiftçi, Gülşen Akalin ^a   Yildirim, Şafak Ulusoylar ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Anticancer activity; Caspase 3 activation; MTT assay; Pyrazoline

Indexed keywords

1 ACETYL 3 (2 THIENYL) 5 ARYL 2 PYRAZOLINE DERIVATIVE; ACETIC ACID; HYDRAZINE; MITOXANTRONE; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; PYRAZOLES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84887438909     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.724682     Document Type: Article

References (32)

1. Silverman RB. The organic chemistry of drug design and drug action. Burlington: Elsevier Academic Press USA, 2004; pp 298-302
2. Singh S, Saxena AK. 2D-QSAR of purine-scaffold novel class of Hsp90 binders that inhibit the proliferation of cancer cells. Med Chem Res 2008;17:290-296
3. Nussbaumer S, Bonnabry P, Veuthey JL, Fleury-Souverain S. Analysis of anticancer drugs: A review. Talanta 2011;85:2265-2289
4. Gupta SP. Quantitative structure-Activity relationship studies on anticancer drugs. Chem Rev 1994;94:1507-1551
5. Galmarini CM, Mackey JR, Dumontet C. Nucleoside analogues: Mechanisms of drug resistance and reversal strategies. Leukemia 2001;15:875-890
6. Shaharyar M, Abdullah MM, Bakht MA, Majeed J. Pyrazoline bearing benzimidazoles: Search for anticancer agent. Eur J Med Chem 2010;45:114-119
7. Kumar S, Bawa S, Drabu S, Kumar R, Gupta H. Biological activities of pyrazoline derivatives-A recent development. Recent Pat Antiinfect Drug Discov 2009;4:154-163
8. Rahman A, Siddiqui AA. Pyrazoline derivatives: A worthy insight into the recent advances and potential pharmacological activities. Int J Pharm Sci Drug Res 2010;2:165-175
9. Congiu C, Onnis V, Vesci L, Castorina M, Pisano C. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Bioorg Med Chem 2010;18:6238-6248
10. Al-Abdullah ES. Synthesis and anticancer activity of some novel tetralin-6-yl-pyrazoline, 2-Thioxopyrimidine, 2-oxopyridine, 2-Thioxo-pyridine and 2-iminopyridine derivatives. Molecules 2011;16:3410-3419
11. Bano S, Javed K, Ahmad S, Rathish IG, Singh S, Alam MS. Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents. Eur J Med Chem 2011;46:5763-5768
12. Bashir R, Ovais S, Yaseen S, Hamid H, Alam MS, Samim M et al. Synthesis of some new 1,3,5-Trisubstituted pyrazolines bearing benzene sulfonamide as anticancer and anti-inflammatory agents. Bioorg Med Chem Lett 2011;21:4301-4305
13. Havrylyuk D, Zimenkovsky B, Vasylenko O, Zaprutko L, Gzella A, Lesyk R. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur J Med Chem 2009;44:1396-1404
14. Omar MT. Synthesis of 1-(heterocyclic substituted anilino)-9Hthioxanthon- 9-ones and their antitumor activity. Arch Pharm Res 1997;20:610-619
15. Johnson M, Younglove B, Lee L, LeBlanc R, Holt H Jr, Hills P et al. Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4. Bioorg Med Chem Lett 2007;17:5897-5901
16. Farghaly A-R. Synthesis of some new indole derivatives containing pyrazoles with potential antitumor activity. ARKIVOC 2010;11:177-187
17. Huang S, Lin R, Yu Y, Lu Y, Connolly PJ, Chiu G et al. Synthesis of 3-(1H-benzimidazol-2-yl)-5-isoquinolin-4-ylpyrazolo[1,2-b] pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor. Bioorg Med Chem Lett 2007;17:1243-1245
18. Zhu GD, Gong J, Gandhi VB, Woods K, Luo Y, Liu X et al. Design and synthesis of pyridine-pyrazolopyridine-based inhibitors of protein kinase B/Akt. Bioorg Med Chem 2007;15:2441-2452
19. Manna F, Chimenti F, Fioravanti R, Bolasco A, Secci D, Chimenti P et al. Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein. Bioorg Med Chem Lett 2005;15:4632-4635
20. Patani GA, LaVoie EJ. Bioisosterism: A Rational Approach in Drug Design. Chem Rev 1996;96:3147-3176
21. Lima LM, Barreiro EJ. Bioisosterism: A useful strategy for molecular modification and drug design. Curr Med Chem 2005;12:23-49
22. Al-Obaid AM, Abdel-Hamide SG, El-Kashef HA, Abdel-Aziz AA, El-Azab AS, Al-Khamees HA et al. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-Thieno-4(3H)- quinazolinone analogs. Eur J Med Chem 2009;44:2379-2391
23. Basnet A, Thapa P, Karki R, Choi H, Choi JH, Yun M et al. 2,6-Dithienyl-4-furyl pyridines: Synthesis, topoisomerase I and II inhibition, cytotoxicity, structure-Activity relationship, and docking study. Bioorg Med Chem Lett 2010;20:42-47
24. Barresi V, Condorelli DF, Fortuna CG, Musumarra G, Scirè S. In vitro antitumor activities of 2,6-di-[2-(heteroaryl)vinyl]pyridines and pyridiniums. Bioorg Med Chem 2002;10:2899-2904
25. Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999;6:99-104
26. Khalaf AA, Kabli RA, Zimaity MT, Khalil AM, Kaddah AM, Al-Rifaie HA. N-Derivatisation of some 3-(2-furyl)-And 3-(2-Thienyl)-5-Aryl-2-pyrazolines. Indian J Chem 1993;32B:1125-1129
27. Mossmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63
28. Keiser K, Johnson CC, Tipton DA. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J Endod 2000;26:288-291
29. Malíková J, Swaczynová J, Kolár Z, Strnad M. Anticancer and antiproliferative activity of natural brassinosteroids. Phytochemistry 2008;69:418-426
30. Wang GW, Klein JB, Kang YJ. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes. J Pharmacol Exp Ther 2001;298:461-468
31. Cotter TG, Martin SJ. Techniques in apoptosis (A User?s Guide). London: Portland Press UK, 1996; pp 107-120
32. Nugraheni M, Santoso U, Wuryastuti H. In vitro antioxidant, antiproliferative and apoptosis effect of Coleus tuberosus L. Afr J Food Sci 2011;5:232-241